---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284595075.md"
description: "OSR Holdings shares are trading lower after the company announced a license agreement for its VXM01 immunotherapy that includes up to $815 million in milestone payments."
datetime: "2026-04-29T14:04:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284595075.md)
  - [en](https://longbridge.com/en/news/284595075.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284595075.md)
generator: "portal-rs"
---

# 

OSR Holdings shares are trading lower after the company announced a license agreement for its VXM01 immunotherapy that includes up to $815 million in milestone payments.

### Related Stocks

- [OSRHW.US](https://longbridge.com/en/quote/OSRHW.US.md)
- [OSRH.US](https://longbridge.com/en/quote/OSRH.US.md)

## Related News & Research

- [Emerging Growth Research Issues Company-Sponsored Research Flash Report on OSR Health, Inc. | OSRH Stock News](https://longbridge.com/en/news/297232863.md)
- [OSR Health CEO says two subsidiaries draw out-licensing interest as Nasdaq bid deadline nears](https://longbridge.com/en/news/295540141.md)
- [11:30 ETWho Are the Fastest-Growing Wealth Management Firms in South Florida? Global Wealth Management Recognized for a Third Year](https://longbridge.com/en/news/297208909.md)
- [OSR Holdings Shareholders Approve Governance and Capital Moves](https://longbridge.com/en/news/295426928.md)
- [OSR Health CEO Reaffirms Confidence and Highlights Subsidiary Business Development | OSRH Stock News](https://longbridge.com/en/news/295540447.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**